To The Moon

🌟🌟🌟When the market catches a temporary cold, the best investors look at the immune system.   There was a lot of chatter on Thursday 5 November 2026 about $DBS(D05.SI)$  dropping a 5% year on year  in Q3 2026 net profit to SGD 2.81 billion.  The short term crowd is scrambling and the stock took a minor hit down to the SGD 69 to SGD 71 range.  But if you look past the headlines and focus on the sheer, unshakeable strength of this business, DBS remains a long term buy.

Why One Quarter Does Not Make or Break DBS

Let's be honest.  We are talking about DBS,  the largest bank in Southeast Asia.   It is a financial fortress that holds a legendary row of awards.  DBS was named Global Bank of the Year by The Banker.  It also made history as the World's Best Bank multiple times across Euromoney and Global Finance.  This is corporate royalty we are talking about.

A single quarter's earnings represent a momentary snapshot, not a structural shift.  The headline profit miss was entirely driven by a 65% nosedive in the markets trading income to SGD 152 million due to unfavourable equity market conditions.

CEO Tan Su Shan noted that trading accounts for about 6% of total income.  This means that fluctuations in trading have a relatively modest direct impact on DBS's core earnings.

Core Drivers:

The bulk of DBS's revenue comes from its commercial book including SGD 3.71 billion in net interest income and SGD 1.43 billion in net fee income (with strong performance in wealth management).   Net Interest Income rose 4% year on year to SGD 3.71 billion  while net fee income grew 6% to SGD 1.43 billion.  This brings total Q3 income to SGD 5.85 billion.  

DBS's Wealth Management:

DBS's Wealth Management segment acted as a vital cushion in Q3 2026, delivering standout asset growth that offset the weakness in market trading.

Assets under management (AUM) hit new records. Total AUM skyrocketed to a record SGD 544 billion.  This is up 16% year on year and 5% higher quarter on quarter.

Broader Wealth Ecosystem Contributions:

Treasury Sales : Robust demand for wealth products also trickled into other financial segments.  Treasury customer sales to wealth and corporate clients propelled a 19% rise in 9 month commercial book other non interest income to SGD 1.97 billion.

Financing Products: Wealth management borrowing patterns also injected momentum into lending metrics, helping anchor a 3% quarter on quarter increase in total loans.

DBS's Non Performing Loan (NPL) ratio improved to 0.90% for Q3 2026.

Rock Solid Capital Buffers :

DBS is sitting on an incredibly health Common Equity Tier 1 (CET1) ratio of 15.9%.   This adjusts upward to a stellar 16.1% CET1 ratio following MAS lowering its operational risk capital penalty multiplier.

The Ultimate Consolation Prize:

Even on a "bad day" DBS Board declared a total Q3 2026 dividend of SGD 0.81 cents per share.  This comprises of 66 cents ordinary plus 15 cents capital return.  At these levels, DBS is locking in a mouth watering forward dividend yield of 4.6%.

What Do Analysts Say?

Analysts maintain strong long term conviction with the consensus average target price at SGD 79.24.

Jefferies - SGD 91.00 Buy.  They are bullish on structural capital management.  Jefferies notes that DBS's peerless CET1 capital strength provides a massive buffer to aggressively sustain high capital return payouts.

Citi Research - SGD 86.80 Buy.   Citi said that DBS is evolving into a wealth led institution, citing high margin, recurring wealth management fees are decoupling the bank's profits from interest rate dependencies.

UOB Kay Hian -SGD 83.60 Buy, citing robust loan book resilience.  Analysts highlight that DBS's balance sheet is outpacing the system, with steady loan and deposit expansion anchoring revenue.

Macquarie - SGD 80.74 Buy, citing DBS's digital optimisation and regulatory relief.  Macquarie flags the MAS's decision to cut the operational risk capital multiplier from 1.8x to 1.5x, immediately freeing up significant capital flexibility.

CGS - SGD 79.50 Buy, citing DBS's best in class Return on Equity (ROE).  CGS focuses on DBS's superior 17.0% ROE and an attractive forward dividend yield heading into 2027.

My Personal Trading Experience: Why Zooming Out Wins 

If you want proof that patience pays, check out my DBS investment.  I bought into DBS back in January 2021.  Fast forward to today and I am up a massive 206% on that investment.

How did that happen?  It didn't happen by obsessing over single quarter trading misses or stressing over minor market pullbacks.  It happened by letting DBS - the best Singapore bank, execute its multi year strategy while quietly compounding my capital.  This return on capital does not include the nice juicy dividends that I have collected over the years.

The Final Verdict : Do Not Interrupt the Masterclass 

Markets are reactive, emotional and chronically short sighted.  They will panic over a temporary trading dip, only to chase the stock higher tomorrow when good news roll back into the headlines.

If you are looking to trade the noise, good luck timing the tantrums of the equity market.  But if you are building actual wealth, you look at DBS's adjusted 16.1% CET1 ratio, smile at the 81 cents payout and let the best bank in the region do what it does best.

The legendary Charlie Munger sums it up perfectly:

"The first rule of Compounding is to never interrupt it unnecessarily".

Selling a dominant, award winning powerhouse over a minor quarterly dip isn't just an interruption.  It is an investment sin.  Lock you shares away, reinvest those fat dividends and let the compounding machine run.

$DBS(D05.SI)$  remains a high conviction, long term buy.

@Tiger_SG  @TigerStars  @Tiger_comments